See the DrugPatentWatch profile for vascepa

Based on the information provided, there is no direct evidence or studies indicating how Vascepa, a prescription drug used to lower triglyceride levels, affects probiotic absorption.

Vascepa, whose active ingredient is icosapent ethyl, works by reducing the production of triglycerides in the body [1]. Probiotics, on the other hand, are live bacteria and yeasts that are beneficial for health, especially the digestive system [2].

There is no evidence suggesting that Vascepa directly interferes with the absorption or utilization of probiotics in the digestive system. However, it is always recommended to consult with a healthcare provider or pharmacist for personalized advice, as drug interactions can vary depending on individual health conditions and other factors.

In general, drug interactions with probiotics are not well-studied, and more research is needed to fully understand the potential interactions between drugs and probiotics [3].

Sources:

1. "[Vascepa (Icosapent Ethyl) Capsules, for Oral Use]." FDA, FDA, 2013, www.accessdata.fda.gov/drugsatfda_docs/label/2013/202653s000lbl.pdf.
2. "Probiotics - What Are They? - NCCIH." National Center for Complementary and Integrative Health, U.S. Department of Health and Human Services, 2019, www.nccih.nih.gov/health/probiotics-what-are-they.
3. Al Martini, William C., et al. "Clinical Significance of Probiotics in Gastrointestinal Disorders Other Than Infectious Diarrhea." Clinical Gastroenterology and Hepatology, vol. 11, no. 12, 2013, pp. 1314-1320., doi:10.1016/j.cgh.2013.07.011.